BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6118908)

  • 1. Dosimetry of the atomic bomb survivors.
    Sinclair WK; Failla P
    Radiat Res; 1981 Dec; 88(3):437-47. PubMed ID: 6118908
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M
    J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimation of whole-body doses by means of chromosome aberrations observed in survivors of the Hiroshima A-bomb.
    Randolph ML; Brewen JG
    Radiat Res; 1980 May; 82(2):393-407. PubMed ID: 7375639
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M; Schull WJ
    Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 6. Thermoluminescence dosimetry of gamma rays from the atomic bomb at Hiroshima using the predose technique.
    Nagatomo T; Ichikawa Y; Ishii H; Hoshi M
    Radiat Res; 1988 Feb; 113(2):227-34. PubMed ID: 3340729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS DERIVED FROM THE EXCESS RELATIVE RISK MODEL WITH THE ATOMIC BOMB SURVIVORS DATA MANAGED BY HIROSHIMA UNIVERSITY.
    Satoh K; Yasuda H; Kawakami H; Tashiro S
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):346-350. PubMed ID: 29036656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S values are not a signature for a significant contribution of neutrons to the radiation dose received by atomic-bomb survivors.
    Nakano M; Kodama Y; Ohtaki K; Itoh M; Nakamura N
    Int J Radiat Biol; 1999 Jan; 75(1):47-9. PubMed ID: 9972790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
    Gilbert ES; Ohara JL
    Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ dose estimates for the Japanese atomic-bomb survivors.
    Kerr GD
    Health Phys; 1979 Oct; 37(4):487-508. PubMed ID: 536212
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-energy gamma rays in Hiroshima and Nagasaki: implications for risk and WR.
    Straume T
    Health Phys; 1995 Dec; 69(6):954-6. PubMed ID: 7493812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Europium-152 activity induced by Hiroshima atomic bomb neutrons: comparison with the 32P, 60Co, and 152Eu activities in dosimetry system 1986 (DS86).
    Hoshi M; Yokoro K; Sawada S; Shizuma K; Iwatani K; Hasai H; Oka T; Morishima H; Brenner DJ
    Health Phys; 1989 Nov; 57(5):831-7. PubMed ID: 2592219
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution in zigzag--the changing state of A-bomb dosimetry.
    Kellerer AM; Rühm W
    J Radiol Prot; 2002 Dec; 22(4):337-9. PubMed ID: 12546221
    [No Abstract]   [Full Text] [Related]  

  • 17. Thermoluminescence dosimetry of gamma rays from the Hiroshima atomic bomb at distances of 1.27 to 1.46 kilometers from the hypocenter.
    Ichikawa Y; Nagatomo T; Hoshi M; Kondo S
    Health Phys; 1987 Apr; 52(4):443-51. PubMed ID: 3570787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of neutrons from the atomic bomb at Hiroshima for revised radiation risk estimates.
    Brenner DJ
    Health Phys; 1991 Mar; 60(3):439-42. PubMed ID: 1995516
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors.
    Hayashi T; Morishita Y; Kubo Y; Kusunoki Y; Hayashi I; Kasagi F; Hakoda M; Kyoizumi S; Nakachi K
    Am J Med; 2005 Jan; 118(1):83-6. PubMed ID: 15639214
    [No Abstract]   [Full Text] [Related]  

  • 20. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation.
    Otake M; Neriishi K; Schull WJ
    Radiat Res; 1996 Sep; 146(3):339-48. PubMed ID: 8752314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.